Case Studies
-
Animal component free (ACF) media development for cell therapies
ACF media achieved comparable performance to serum containingReleased by: CCRM
-
Process Development for Scaled-up hESC/hiPSC Manufacturing
An optimized 14-day manufacturing workflow which produces > 10^10 , cells was developed in < 12 monthsReleased by: CCRM
-
Cost-Effective Solution to Filing Your CMC Supplement
Opioid Reformulation for Abuse Deterrence — Filed as a CMC Supplement in Less Than a YearReleased by: Recro Gainesville
-
Systech and Sharp Deliver Revolutionary Brand Protection
Did you know there are three pillars that ensure effective brand protection? Serialization alone can’t do it. Download this use case to learn more.Released by: Systech
-
-
-
-
-
New Molding Capability Enhances Product Quality And Shortens Supply Chain
How Pharma Tech Industries Proactively Turned A Challenge Into An Opportunity To Better Serve Customers.Released by: Pharma Tech Industries
-
A Billion Reasons Why Innovation Works
How Pharma Tech Industries Turned A Complicated Effervescent Transfer Into A Manufacturing Milestone.Released by: Pharma Tech Industries
-
A Defining Moment In Acquiring World-Class Expertise
How Pharma Tech Industries Turned Its First Major Technology Transfer Into A Blueprint For Success.Released by: Pharma Tech Industries
-
Pharma Tech Makes Life-Saving Product Easier To Digest
How Pti Teamed With Daiichi Sankyo Pharmaceuticals To Reformulate Its Existing Cholesterol Product Into A New Dosage FormReleased by: Pharma Tech Industries
-
Serialisation expertise: How Sharp responds to market demands
Our expertise and commitment to innovation ensured we met the market challenges for our client.Released by: Sharp Packaging
-
Communicating Occupational Hazards Through Colour
This employee-driven initiative resulted in what is called the Occupational Exposure Band (OEB) system.Released by: Sharp Packaging
-
Five Year Trouble Free Manufacturing for Large Pharma Company
Summary A large pharmaceutical contract manufacturing engagement demonstrating five years trouble free supply with OTIF (On-Time-In-Full) consistently >95%. Process and product improvement initiatives were also delivered, which enabled significan…Released by: Alkermes
-
Product & Process Transfer of Low Solubility Compound with 6 year OTIF>95%
Summary The successful transfer of a low solubility compound into one of Alkermes manufacturing sites achieving as a result, an OTIF (On-Time-In-Full) consistently over 95%.…Released by: Alkermes
-
APIs
Highly Potent Technical Transfer and Commercial Manufacturing
Alkermes’ successful approach to commercialscal final dosage manufacture of drug product containing highly potent API Project History • Donor site capacity issue where the company was seeking an outsourcing manufacturing partner for co…Released by: Alkermes
-
Process Validation | Validation
Joint Risk Assessment During Technical Transfer
A framework for donor and recipient companies to jointly analyze and document the technical and business risks associated with a technical transfer To help drive the tech transfer of partner products, Alkermes sought to develop a risk assessment f…Released by: Alkermes
-
SoluPath™ Offers Efficiency in Multiple Ways
SoluPath™ employs parallel screening of multiple solubility and bioavailability enhancing technologies for a fixed price. That alone adds speed in the race to First In Man trials. But it’s the way Patheon delivers this service that maximi…Released by: Thermo Fisher Scientific
-
SoluPath™ Improves Bioavailability by 4x in Just Three Months
A small biotech company was developing a compound with poor solubility and bioavailability. Patheon’s SoluPath™ parallel screening service quickly and cost-effectively determined the best formulation to overcome these issues.…Released by: Thermo Fisher Scientific
